Neurocrine Biosciences (NBIX) Reports In-Line Q3 EPS

Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21).

For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Limoneira sells vineyard property for $15M at public auction